Atlas Trials

The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal

Clinical trial NCT03579589 · COMPLETED

Trial details

NCT number
NCT03579589
Sponsor
Ohio State University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuromuscular Blockade
Start date
2018-08-15
Primary completion
2019-12-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.